117
Participants
Start Date
July 2, 2014
Primary Completion Date
March 19, 2016
Study Completion Date
March 19, 2016
Dutasteride
Dutasteride will be supplied as soft gelatin capsules, containing 0.5 mg of dutasteride to be administered orally.
Placebo
Dutasteride matching placebo will be supplied as capsules to be administered orally.
GSK Investigational Site, Taipei
GSK Investigational Site, Singapore
GSK Investigational Site, Santiago
GSK Investigational Site, Pokfulam
GSK Investigational Site, Shatin
GSK Investigational Site, Chungcheongnam-do
GSK Investigational Site, Taipei
GSK Investigational Site, Daejeon
GSK Investigational Site, Gwangju
GSK Investigational Site, Gyeonggi-do
GSK Investigational Site, Incheon
GSK Investigational Site, Jeonju-si, Jeollabuk-do
GSK Investigational Site, Kangwon-Do
GSK Investigational Site, Pusan
GSK Investigational Site, Seoul
GSK Investigational Site, Seoul
GSK Investigational Site, Seoul
GSK Investigational Site, Seoul
Collaborators (1)
GlaxoSmithKline
INDUSTRY
Stiefel, a GSK Company
INDUSTRY